Eye Health News and Research

Latest Eye Health News and Research

Genetic susceptibility, dietary antioxidants combine to reduce AMD risk

Dietary intake of antioxidants is associated with a reduced risk of developing early age-related macular degeneration in people at high genetic risk of the condition, pooled analysis of two studies suggests.

1 May 2014

Support for internal limiting membrane peeling for full-thickness macular holes

Vitrectomy with peeling of the internal limiting membrane of the retina improves the outcome of idiopathic full-thickness macular hole surgery compared with no peeling, study findings show.

1 May 2014

Single treatment for AMD 'unlikely'

Age-related macular degeneration does not follow the same disease course from one patient to another, conclude researchers who suggest that phenotyping may be important before initiating a therapeutic trial.

1 May 2014

Retinal measurements associated with Parkinson’s disease duration

The inner retinal layers in the eyes of patients with Parkinson’s disease are thinner than those of healthy people’s eyes, except for the inner nuclear layer, which is thicker, show the results of a prospective study involving the latest optical coherence tomography methods.

1 May 2014

Early gene therapy could improve choroideremia prognosis

Retinal gene therapy could prevent loss of vision in patients with choroideremia and other retinal diseases, show the results of a phase I/II study.

30 Apr 2014

Restoring vision in patients with retinitis pigmentosa: an interview with Dr. Gregoire Cosendai, Vice President, Europe, Second Sight

Retinitis pigmentosa (RP) is a progressive eye disease that leads to untreatable blindness. The name of the disease derives from the fact that one of the areas affected by the disease is the retinal pigment epithelium (RPE) in the back of the eye.

30 Apr 2014

Cutting-edge EmbryoScope technology now available to couples seeking fertility treatment in Florida

The latest in cutting-edge technology, The EmbryoScope, is now available to couples seeking fertility treatment in Florida at IVF FLORIDA Reproductive Associates.

30 Apr 2014

LCA-Vision's revenues decrease $25.5M to 9.8% in first quarter 2014

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operating results for the three months ended March 31, 2014.

30 Apr 2014

Free educational event for patients with Graves' disease and thyroid eye disease

The Massachusetts Eye and Ear and the Graves' Disease & Thyroid Foundation will host a free educational event for patients living with Graves' disease and thyroid eye disease on Saturday, May 10 from 8:30 a.m. to noon at Mass. Eye and Ear's Meltzer Auditorium, 3rd floor, 243 Charles Street, Boston, Mass., 02114.

30 Apr 2014

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.

28 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

Antimicrobial peptide coated contact lenses may reduce risk of contact lens-related infections

Contact lenses coated with an antimicrobial peptide could help to lower the risk of contact lens-related infections, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Apr 2014

Prestige Brands Holdings signs agreement to acquire Insight Pharmaceuticals for $750 million

Prestige Brands Holdings, Inc. today announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter ("OTC") healthcare products, for $750 million in cash.

25 Apr 2014

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.

From Roche Sequencing and Life Science 25 Apr 2014

NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid Cleanser.

23 Apr 2014

Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic products based on the company's proprietary Mucus Penetrating Particle (MPP) platform technology, today announced it has completed a $22.5 million Series B financing.

23 Apr 2014

Glaucoma drug may help reverse obesity-related vision loss in women

An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health.

23 Apr 2014

Sleep disorder is the best current predictor of brain diseases, say U of T researchers

Researchers at the University of Toronto say a sleep disorder that causes people to act out their dreams is the best current predictor of brain diseases like Parkinson's and Alzheimer's.

22 Apr 2014

NBTY introduces Nature's Origin, a complete line of nutritional supplements

NBTY, Inc., a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, introduces Nature's Origin, its first complete line of vitamins, minerals and herbal supplements that are free from ingredients made with GMOs, preservatives, gluten and irradiation.

22 Apr 2014

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.

22 Apr 2014

Eye Health News and Research

Latest Eye Health News and Research

Genetic susceptibility, dietary antioxidants combine to reduce AMD risk

Support for internal limiting membrane peeling for full-thickness macular holes

Single treatment for AMD 'unlikely'

Retinal measurements associated with Parkinson’s disease duration

Early gene therapy could improve choroideremia prognosis

Restoring vision in patients with retinitis pigmentosa: an interview with Dr. Gregoire Cosendai, Vice President, Europe, Second Sight

Cutting-edge EmbryoScope technology now available to couples seeking fertility treatment in Florida

LCA-Vision's revenues decrease $25.5M to 9.8% in first quarter 2014

Free educational event for patients with Graves' disease and thyroid eye disease

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Antimicrobial peptide coated contact lenses may reduce risk of contact lens-related infections

Prestige Brands Holdings signs agreement to acquire Insight Pharmaceuticals for $750 million

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

NovaBay introduces new eye care product to help patients with eyelids irritation

Kala Pharmaceuticals completes $22.5 million Series B financing

Glaucoma drug may help reverse obesity-related vision loss in women

Sleep disorder is the best current predictor of brain diseases, say U of T researchers

NBTY introduces Nature's Origin, a complete line of nutritional supplements

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Genetics & Genomics - Second Edition eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in